Company Profiles

driven by the PitchBook Platform

ValenTx

Description

Developer of less invasive treatments for morbid obesity. The company has been developing a non-surgical, implantable medical therapy to treat morbid obesity and Type II Diabetes.

2002

Founded

PRIVATE

Status

11-50

Employees

Debt

Latest Deal Type

$4.11M

Latest Deal Amount

$35.5M

Total Amount Raised

Description

Developer of less invasive treatments for morbid obesity. The company has been developing a non-surgical, implantable medical therapy to treat morbid obesity and Type II Diabetes.

Website:

www.valentx.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Therapeutic Devices

Primary Office

6901 East Fish Lake Road Suite 118 Maple Grove, MN 55369United States +1 (763) 222-1560
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore ValenTx's full profile, request a free trial.

ValenTx Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

ValenTx Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

ValenTx Investors (7)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Affinity Capital ManagementVenture CapitalMinority000 0000000 0000
Covidien VenturesCorporate Venture CapitalMinority000 0000000 0000
EDF VenturesVenture CapitalMinority000 0000000 0000
Kaiser Permanente VenturesCorporate Venture CapitalMinority000 0000000 0000
Sapient Capital ManagementVenture CapitalMinority000 0000000 0000
Affinity Capital Management Venture Capital
Covidien Ventures Corporate Venture Capital
EDF Ventures Venture Capital
Kaiser Permanente Ventures Corporate Venture Capital
Sapient Capital Management Venture Capital

ValenTx Executive Team (9)

NameTitleBoard
Seat
Contact
Info
Jon St. GermainChief Executive Officer
David KrennChief Financial Officer
Stephen MorrisonChief Financial Officer
Terry DahlDirector, Engineering
Phil Zhang MDSenior Director, Clinical Research
Jon St. Germain Chief Executive Officer
David Krenn Chief Financial Officer
Stephen Morrison Chief Financial Officer
Terry Dahl Director, Engineering
Phil Zhang MD Senior Director, Clinical Research

ValenTx Board Members (6)

NameRepresentingRoleSinceContact
Info
Bob GriffinSelfBoard Member000 0000
David SchulteKaiser Permanente VenturesVice President & Senior Managing Director000 0000
Elizabeth RockettKaiser Permanente VenturesDirector000 0000
Mary CampbellEDF VenturesFounder & Managing Director000 0000
Mitchell DannSelfChairman & Founder000 0000
Bob Griffin Board Member Self
David Schulte Vice President & Senior Managing Director Kaiser Permanente Ventures
Elizabeth Rockett Director Kaiser Permanente Ventures
Mary Campbell Founder & Managing Director EDF Ventures
Mitchell Dann Chairman & Founder Self
Request full access to PitchBook